Severe outcomes have been particularly observed in patients with coexisting chronic inflammatory conditions, such as hypertension, diabetes, and obesity, which are in turn linked with elevated plasma GDF-15 levels (76). This evidence concerns the gene GDF15 and diabetes mellitus.